<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0216308.ref034">
 <label>34</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Brendish</surname>
   <given-names>NJ</given-names>
  </name>, 
  <name>
   <surname>Malachira</surname>
   <given-names>AK</given-names>
  </name>, 
  <name>
   <surname>Armstrong</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Houghton</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Aitken</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Nyimbili</surname>
   <given-names>E</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial</article-title>. 
  <source>Lancet Respir Med</source>. 
  <year>2017</year>;
  <volume>5</volume>(
  <issue>5</issue>):
  <fpage>401</fpage>â€“
  <lpage>11</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S2213-2600(17)30120-0</pub-id>
  <?supplied-pmid 28392237?>
  <pub-id pub-id-type="pmid">28392237</pub-id>
 </mixed-citation>
</ref>
